Health News
Executive director of Patients Come First: 'The biggest flaw in the 340B program is that the discounts don’t have to go to the beneficiaries'
Concerns are mounting over the federal 340B drug pricing program, which was intended to provide affordable medications to low-income patients, as evidence suggests that some large health systems are using the program’s benefits to generate profits. The 340B program, established to supply safety-net hospitals with deeply discounted drugs, is now the second-largest federal prescription drug initiative, surpassing Medicare Parts B and D in scale.
In New Jersey, 242 people have died after receiving COVID-19 “vaccine”
New Jersey registered 242 deaths after admission of a “COVID-19” MRNA injection, according to the Vaccine Adverse Event Reporting System (VAERS).
Latest News
